Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2021
2021 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
-
+
P56 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Histopathology
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 6
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P56.01 - Semiquantitative Assessment of Tumor Spread Through Air Spaces in a Historic Cohort of Lung Adenocarcinomas Following Open Surgical Resection
00:00 - 00:00 | Presenter: WEIWEI SHI
- Abstract
Loading... -
+
P56.02 - Novel Low Malignant Potential/Vascular Invasive (LMPVI) Grade is Superior to WHO 2015 and IASLC 2020 Adenocarcinoma Grade
00:00 - 00:00 | Presenter: Ilyas Yambayev
- Abstract
Loading... -
+
P56.03 - Prognostic Value of Tumor Spread Through Air Spaces in Patients With Lung Adenocarcinoma after Radical Surgery
00:00 - 00:00 | Presenter: Shiqi Chen
- Abstract
Loading... -
+
P56.04 - Pathological Features & Prognosis of NSCLC Patients With Enteric Adenocarcinomas Without Expression of TTF-1 and Napsin A
00:00 - 00:00 | Author(s): Franziska Kraus
- Abstract
Loading... -
+
P56.05 - Detection Rate and Prognosis of Nodal-Micro Metastasis by IHC in pN0 Resectable Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: sophon - Siwachat
- Abstract
Loading... -
+
P56.06 - Clinical Significance and Potential Function of S100A10 in Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Jiyan Dong
- Abstract
Loading...
-
+
P57 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - ICI Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 16
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P57.01 - Immunotherapy Fits Everyone? Prognostic Markers for Immune-checkpoint-Inhibitor (ICI) in Non-small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Susana Baptista de Almeida
- Abstract
Loading... -
+
P57.02 - Integration of Systemic / Tumor PD-L1 as a Predictive Biomarker of Clinical Outcome in Advanced NSCLC Patients Treated With Anti-PD-(L)1 Agents
00:00 - 00:00 | Author(s): Georgia Anguera Palacios
- Abstract
Loading... -
+
P57.03 - Cellular Engagement and Interaction in the Tumor Microenvironment (TME) Predicts Response to ICI in Metastatic NSCLC
00:00 - 00:00 | Presenter: Angel Qin
- Abstract
Loading... -
+
P57.04 - Predicting Treatment Response to 1st- line Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients with High PDL1 Expression
00:00 - 00:00 | Presenter: Ian K. N. Janzen
- Abstract
Loading... -
+
P57.05 - Low Variant Allele Frequency of TP53 as a Biomarker for PD-1/PD-L1 Inhibitors in Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Shouzheng Wang
- Abstract
Loading... -
+
P57.06 - EGFR Mutational Status and PD-L1 in Early-Stage Brazilian Non-Small-Cell Lung Cancer
00:00 - 00:00 | Author(s): Rodrigo de Oliveira Cavagna
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
P57.07 - The Scottish Immunotherapy Prognostic Score (SIPS) Predicts Response to First-Line Pembrolizumab for Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Mark Stares
- Abstract
Loading... -
+
P57.08 - High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC
00:00 - 00:00 | Presenter: Giulia Mazzaschi
- Abstract
Loading... -
+
P57.09 - Common Oncogenic Driver Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer of Smokers and Never Smokers
00:00 - 00:00 | Presenter: Chong Kin Liam
- Abstract
Loading... -
+
P57.10 - Clinicopathological Analysis of Anti-Tumor Immunology-Related Factors After Chemoradiotherapy for Lung Cancer
00:00 - 00:00 | Presenter: Misa Noguchi
- Abstract
Loading... -
+
P57.11 - The Role of Serum Proteomic Signature in Predicting Survival by PD-L1 Status in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy
00:00 - 00:00 | Presenter: Leeseul Kim
- Abstract
Loading... -
+
P57.12 - Clinical and Molecular Features of Chinese Lung Cancer Patients With Germline Mismatch Repair Gene Mutations
00:00 - 00:00 | Presenter: Jing Bai
- Abstract
Loading... -
+
P57.13 - Correlation of TP53/KMT2C co-mutation and Tumor Microenvironment in Lung Cancer
00:00 - 00:00 | Presenter: Xuhui Zhang
- Abstract
Loading... -
+
P57.14 - LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
00:00 - 00:00 | Presenter: xin jin
- Abstract
Loading... -
+
P57.15 - Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Low Creatinine Clearance Rate
00:00 - 00:00 | Presenter: Jia-Yi Deng
- Abstract
Loading... -
+
P57.16 - Inflammatory Markers as Predictors of Treatment Response and Survival in Patients With Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors
00:00 - 00:00 | Author(s): Ioannis Tourkantonis
- Abstract
Loading...
-
+
P58 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Predictive Biomarkers/ Pathology
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 1
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P58.01 - Dysbiosis of Fecal Microbiome in Advanced Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Xueqin Chen
- Abstract
Loading...
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 32
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P59.01 - Clinical Characteristics of Patients With MET Amplification-Positive NSCLC After EGFR-TKI Therapy
00:00 - 00:00 | Presenter: Ji Hyun Lee
- Abstract
Loading... -
+
P59.02 - Profile of Next-Generation Sequencing (NGS) on MET exon 14 Skipping Mutation and MET Amplification in Lung Cancer: A Calibration Project in China
00:00 - 00:00 | Presenter: Wei Wu
- Abstract
Loading... -
+
P59.03 - Comparison of Two RNA-Based Platforms for Detection of Fusions and Met Splicing Variant in Non Small Cell Lung Cancer Samples
00:00 - 00:00 | Author(s): Beatriz García Peláez
- Abstract
Loading... -
+
P59.04 - Molecular Characterization of Unactionable EGFR Mutation in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: HuiTa Wu
- Abstract
Loading... -
+
P59.05 - Integration of Molecular Cancer Classification and NGS to Identify Metastatic Cancer Patients Eligible For Lung Cancer Directed Therapy
00:00 - 00:00 | Presenter: Kaushal Parikh
- Abstract
Loading... -
+
P59.06 - Prognostic Nutritional Index in Real-World Patients Receiving Systemic Therapy for Driver Mutation-Positive Metastatic NSCLC
00:00 - 00:00 | Author(s): Michelle Liane Dean
- Abstract
Loading... -
+
P59.07 - Mutation Profile of BRAF in Chinese Non-Small Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Xinghao Ai
- Abstract
Loading... -
+
P59.08 - Identifying the Origin of Lung-Specific Cancer of Unknown Primary Based on Comprehensive Genomic Profiling Optimized With DNA Methylation
00:00 - 00:00 | Author(s): Kaiyan Chen
- Abstract
Loading... -
+
P59.09 - Landscape of Targetable Genomic Alterations in Hispanic/Latinx Patients With Non-Small Cell Lung Cancers
00:00 - 00:00 | Presenter: Ana Isabel Velazquez
- Abstract
Loading... -
+
P59.10 - A Sneak Peak in the Future World of EGFR Mutations: ML Based PFS Differences Between Del 19 and L858R
00:00 - 00:00 | Presenter: Ullas Batra
- Abstract
Loading... -
+
P59.11 - Real-World Data of NGS Diagnostic Biomarker Testing for Lung Cancer Patients in Japan
00:00 - 00:00 | Presenter: Toshiaki Takahashi
- Abstract
Loading... -
+
P59.12 - KRAS Mutation Subtypes in Non-Small Cell Lung Cancer and Clinical Outcomes: A Single Centre Experience
00:00 - 00:00 | Presenter: Alexander Patrick Davis
- Abstract
Loading... -
+
P59.13 - The Prediction Performance of TP53 / RB1 Co-Mutation on Small-Cell Lung Cancer Transformation in Patients With Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Zaiwen Fan
- Abstract
Loading... -
+
P59.14 - Concordance and Performance of ddPCR Compared to NGS for The Detection of KRAS G12C Mutation
00:00 - 00:00 | Author(s): Alejandro Ruiz-Patiño
- Abstract
Loading... -
+
P59.15 - Is CD73 Expression a Druggable Mechanism of Resistance in EGFR-TKI-Treated EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)?
00:00 - 00:00 | Presenter: Inger Johanne Eide
- Abstract
Loading... -
+
P59.16 - Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLC
00:00 - 00:00 | Author(s): James Monkman
- Abstract
Loading... -
+
P59.17 - EGFR Mutation Status, Liver Metastasis, and Overall Survival in Advanced Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Preet Walia
- Abstract
Loading... -
+
P59.18 - Evaluation of ROS1 Expression in a Large Cohort of Early Stage Lung Cancer
00:00 - 00:00 | Presenter: Anne Pernille Harlem Dyrbekk
- Abstract
Loading... -
+
P59.19 - MET Alterations and Co-Drivers With Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Maritza Ramos-Ramirez
- Abstract
Loading... -
+
P59.20 - Natural History of KRAS Mutant Non-Small-Cell Lung Cancer in the Immunotherapy Era: A Single-Centre Retrospective Study
00:00 - 00:00 | Presenter: Paolo Bironzo
- Abstract
Loading... -
+
P59.21 - Impact of Reflex Testing on Pathology Based Molecular Testing in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Melina E. Marmarelis
- Abstract
Loading... -
+
P59.22 - Biomarker Testing for Advanced Lung Cancer by Next-Generation Sequencing in Real World Practice
00:00 - 00:00 | Presenter: Jose Nicolas Minatta
- Abstract
Loading... -
+
P59.23 - Biomarker Testing for Non-Small Cell Lung Cancer at a Tertiary Referral Hospital in Ireland: Challenges and Opportunities
00:00 - 00:00 | Presenter: Philip Bredin
- Abstract
Loading... -
+
P59.24 - Genomic Abnormalities in Malignant Pleural Effusion of Lung Cancer Patients Detected by Multiplex Ligation-Dependent Probe Amplification
00:00 - 00:00 | Presenter: Caroline Silvério Faria
- Abstract
Loading... -
+
P59.25 - Prognostic and Treatment Characteristics of Metastatic KRAS G12C Mutant NSCLC
00:00 - 00:00 | Presenter: Anifat Elegbede
- Abstract
Loading... -
+
P59.26 - Comparison of RT-PCR, NGS and FISH/IHC Methods in Detection of Gene Fusions
00:00 - 00:00 | Presenter: Yue Pu
- Abstract
Loading... -
+
P59.27 - Complementary Utility of Combined ALK/ROS1 FISH with Immunohistochemistry for ALK/ROS1 Rearrangement Testing in Lung Cancer
00:00 - 00:00 | Presenter: Aruna Nambirajan
- Abstract
Loading... -
+
P59.28 - Protocol Adaptation for gDNA Extraction of FFPE Samples of Lung Adenocarcinoma Tissue and Related Mediastinal Lymph Nodes
00:00 - 00:00 | Presenter: Caroline Silvério Faria
- Abstract
Loading... -
+
P59.29 - Frequency of PIK3CA Mutations and Therapeutic Outcomes in NSCLC
00:00 - 00:00 | Presenter: Guillermo Martos
- Abstract
Loading... -
+
P59.30 - Genomic Landscape of Lung Cancer in the Young
00:00 - 00:00 | Presenter: Rossana Ruiz
- Abstract
Loading... -
+
P59.31 - A High Number of Co-Current Genetic Alterations Is Associated With Poor Survival in EGFR Mutated Metastatic NSCLC Patients
00:00 - 00:00 | Presenter: David Heredia
- Abstract
Loading... -
+
P59.32 - Physician Attitudes Toward Genetic Testing and Targeted Therapy for Advanced NSCLC Patients in China: A Nationwide Survey
00:00 - 00:00 | Author(s): Meiling Wu
- Abstract
Loading...
-
+
P60 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Other Biomarkers
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
- Presentations: 14
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P60.01 - Investigation of Aurora Kinase A as a Potential Biomarker of Radiation in Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Timothy Mitchell
- Abstract
Loading... -
+
P60.02 - Polymorphisms of APE1(T444G), hOGG1(C977G), XRCC1(G839A), XPD(T2251G), XPG(G3310C), XPC(A2815C) Genes in Lung Cancer Patients
00:00 - 00:00 | Presenter: Marina Leonidovna Bakanova
- Abstract
Loading... -
+
P60.03 - Transcriptome and Genome Profiles of Metastatic Lung Cancers Highlighted Predictive Power of Infection-Related Model in Metastasis
00:00 - 00:00 | Presenter: Peixin Chen
- Abstract
Loading... -
+
P60.04 - TTF1 Expression in Advanced Lung Adenocarcinoma and Survival Outcome: An Observational Study
00:00 - 00:00 | Presenter: Rebecca Chloe Webster
- Abstract
Loading... -
+
P60.05 - Radiomic Signature to Predict Outcomes in EGFR-Mutant Non-Small Cell Lung Cancer
00:00 - 00:00 | Author(s): Jose Nicolas Minatta
- Abstract
Loading... -
+
P60.06 - Systematic Variant Profiling Delineates the Radiogenomic Landscape of Cancer
00:00 - 00:00 | Presenter: Priyanka Gopal
- Abstract
Loading... -
+
P60.07 - Comprehensive Genomic Profiling of Microsatellite Instability-High Lung Cancer in China
00:00 - 00:00 | Presenter: Chengzhi Zhou
- Abstract
Loading... -
+
P60.08 - Systemic Immune-Inflammatory Index (SII) as a Biomarker for Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Samia Asif
- Abstract
Loading... -
+
P60.09 - Real-World Readiness of US Laboratories to Test Metastatic NSCLC Patients for Rare Actionable Genomic Variants by NGS
00:00 - 00:00 | Author(s): Jirawas Sornkom
- Abstract
Loading... -
+
P60.10 - A 27-Gene IO Assay to Capture the Tumor Immune Microenvironment Is Associated With Response in Metastatic and Primary Tumors
00:00 - 00:00 | Presenter: Matthew Gordon Varga
- Abstract
Loading... -
+
P60.11 - Trends in Molecular Testing for Metastatic Non-Small Cell Lung Cancer in The US Oncology Network Community Practices
00:00 - 00:00 | Presenter: Nicholas J Robert
- Abstract
Loading... -
+
P60.12 - Prevalence of c-Met overexpression (c-Met+) and Impact of Prior Lines of Treatment on c-Met Protein Expression in NSCLC
00:00 - 00:00 | Presenter: Monica Motwani
- Abstract
Loading... -
+
P60.13 - MYLUNG Consortium: Molecularly Informed Lung Cancer Treatment in a Community Cancer Network. Pragmatic Prospective RWR Study
00:00 - 00:00 | Presenter: Makenzi Colleen Evangelist
- Abstract
Loading... -
+
P60.14 - A United States Study Focused on Patients’ Understanding of, Attitudes Towards, and Barriers to the Use of Biomarker Testing for NSCLC
00:00 - 00:00 | Presenter: Upal Basu Roy
- Abstract
Loading...
-
+
P61 - Screening and Early Detection - Engagement in Lung Cancer Screening
- Type: Posters
- Track: Screening and Early Detection
- Presentations: 10
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P61.01 - Intelligence Assistant Million Early-Stage Lung Cancer Research Program in China
00:00 - 00:00 | Presenter: Dawei Yang
- Abstract
Loading... -
+
P61.02 - The Use of PLCOm2012 vs PLCOm2012noRace Risk Prediction Models in a UK Lung Cancer Screening Programme
00:00 - 00:00 | Presenter: Patrick Bradley
- Abstract
Loading... -
+
P61.03 - Comparison of the Sensitivity of Different Screening Algorithms to Select Lung Cancer Patients for Screening in a Cohort of German Patients
00:00 - 00:00 | Presenter: Julia Walter
- Abstract
Loading... -
+
P61.04 - Disparities Related to Low-Dose Computed Tomography Screening Eligibility Criteria for Lung Cancer: A Single-Center Analysis
00:00 - 00:00 | Presenter: Samuel Kareff
- Abstract
Loading... -
+
P61.05 - Time to Loosen Up: Liberalizing Lung Cancer Screening Guidelines Might Save More Lives
00:00 - 00:00 | Presenter: Coral Olazagasti
- Abstract
Loading... -
+
P61.06 - Participants With Family History of Cancer Have a Higher Participation Rate of Low-Dose Computed Tomography for Lung Cancer Screening
00:00 - 00:00 | Presenter: Lanwei Guo
- Abstract
Loading... -
+
P61.07 - Advancing Health Equity in Cancer Care: The Lived Experiences of Poverty and Access to Lung Cancer Screening
00:00 - 00:00 | Presenter: Ambreen Sayani
- Abstract
Loading... -
+
P61.08 - A Light Gradient Machine-Enabled Radiomics Model for Survival Prediction in Non-Small-Cell Lung Cancer-Not Otherwise Specified
00:00 - 00:00 | Presenter: Kit Yee Leung
- Abstract
Loading... -
+
P61.09 - Feasibility of Lung Cancer Screening With Low-Dose Computed Tomography in a Rural Community Setting; An 8-Year Experience
00:00 - 00:00 | Presenter: Jacques Townsend
- Abstract
Loading... -
+
P61.10 - Swiss Pilot Low-Dose Computed Tomography Lung Cancer Screening Study
00:00 - 00:00 | Presenter: Lisa M Jungblut
- Abstract
Loading...
-
+
P62 - Screening and Early Detection - Technological Advances for Detection and Prognostication of Early-Stage Lung Cancer
- Type: Posters
- Track: Screening and Early Detection
- Presentations: 11
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P62.01 - PREVALUNG: Evaluation of Lung Cancer Prevalence in Patients With Smocking-associated Atherosclerotic Cardiovascular Diseases
00:00 - 00:00 | Presenter: David Boulate
- Abstract
Loading... -
+
P62.02 - A Predictive Model to Guide Brain MRI Surveillance in Patients With Metastatic Lung Cancer: Impact on Real World Outcomes
00:00 - 00:00 | Presenter: Julie Tsu-Yu Wu
- Abstract
Loading... -
+
P62.03 - Survival After Distant Recurrent Versus De Novo Stage IV Metastatic Lung Cancer Under Low-Dose Computed Tomography Screening
00:00 - 00:00 | Presenter: Chloe Chang Su
- Abstract
Loading... -
+
P62.04 - Neoteric Small Extracellular Vesicles Based Biomarker for Predicting Cancerous Sub-Solid Nodules of Lung
00:00 - 00:00 | Presenter: Nishant Patel
- Abstract
Loading... -
+
P62.05 - Identifying Risk-Factors for Lung Cancer Diagnosis After Detection of Incidental Lung Nodules
00:00 - 00:00 | Author(s): Wei Liao
- Abstract
Loading... -
+
P62.06 - A Radiomics Nomogram for Preoperative Prediction of Occult Lymph Node Metastasis in Early-Stage Solid Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Ran Zhang
- Abstract
Loading... -
+
P62.07 - Pre-surgical Assessment of Mediastinal Lymph Node Metastases in Stage IA Non-small-cell Lung Cancers
00:00 - 00:00 | Presenter: Yeqing Zhu
- Abstract
Loading... -
+
P62.08 - The Non-Intrusive LuCED® Test for Detection of Early-Stage Lung Cancer: A Subgroup Analysis for Chronic Obstructive Pulmonary Disease (COPD)
00:00 - 00:00 | Presenter: Michael Meyer
- Abstract
Loading... -
+
P62.09 - A Prospective Cohort Evaluation of the Sensitivity and Specificity of the Chest X-Ray for the Detection of Lung Cancer in Symptomatic Adults
00:00 - 00:00 | Presenter: Nathaniel Luke Hatton
- Abstract
Loading... -
+
P62.10 - AI-Based Three-Dimension Reconstruction for Pulmonary Nodules -New Auxiliary Exploration for Thoracic Surgery
00:00 - 00:00 | Presenter: Nan Wu
- Abstract
Loading... -
+
P62.11 - Germline Genetic Testing in Patients with Lung Cancer in a Mexican Center
00:00 - 00:00 | Presenter: Guillermo Pacheco-Cuellar
- Abstract
Loading...
-
+
P63 - Small Cell Lung Cancer/ NET - Clinical Studies
- Type: Posters
- Track: Small Cell Lung Cancer/ NET
- Presentations: 15
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P63.01 - Lurbinectedin in Pre-Treated Patients With Small Cell Lung Cancer and Malignant Pleural Mesothelioma in a Real World Setting
00:00 - 00:00 | Presenter: Daphne Dumoulin
- Abstract
Loading... -
+
P63.02 - Exposure-Response Analysis of Lurbinectedin Alone or With Doxorubicin in Overall Survival in Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Salvador Fudio
- Abstract
Loading... -
+
P63.03 - Very Limited SCLC Benefits From Surgery and Adjuvant Chemotherapy – A Large Retrospective Analysis
00:00 - 00:00 | Presenter: Diego Kauffmann-Guerrero
- Abstract
Loading... -
+
P63.04 - Minimum Number of Lymph Node Dissections for Resectable Early-Stage Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Takefumi Komiya
- Abstract
Loading... -
+
P63.05 - Treatment Pattern in Small Cell Lung Cancer: A Real-world Observational Study in the Era of Immune Checkpoint Inhibitors
00:00 - 00:00 | Presenter: Ke Zu
- Abstract
Loading... -
+
P63.06 - Immunotherapy Improved Pathological Response for Resectable Limited Stage Small Cell Lung Cancer- A Case Serial
00:00 - 00:00 | Presenter: Hongxia Li
- Abstract
Loading... -
+
P63.07 - Real World Predictors for Long Term Survival in Stage IV Small Cell Lung Cancer Treated With Standard of Care Chemotherapy
00:00 - 00:00 | Author(s): Rebekah Rittberg
- Abstract
Loading... -
+
P63.08 - Real-World Utilization of Immune Checkpoint Inhibitors in Extensive Stage Small Cell Lung Cancer in Community Settings
00:00 - 00:00 | Presenter: Ke Zu
- Abstract
Loading... -
+
P63.09 - Surgical Management of Cushing's Syndrome Secondary to Lung Carcinoid Tumors: Changing Perspectives
00:00 - 00:00 | Presenter: Kenneth Patrick Seastedt
- Abstract
Loading... -
+
P63.10 - Safety of Simultaneously Performed Radiotherapy in Patients With Small-Cell Lung Cancer Undergoing Atezolizumab Treatment
00:00 - 00:00 | Author(s): Julia Madeleine Galuba
- Abstract
Loading... -
+
P63.11 - Real-World Survival Outcomes of Patients with Limited Stage Small Cell Lung Cancer (LS-SCLC) by Choice of Platinum Chemotherapy
00:00 - 00:00 | Author(s): Kathleen Claire Kerrigan
- Abstract
Loading... -
+
P63.12 - Radiotherapy for Small Cell Lung Cancer in Current Clinical Practice Guidelines
00:00 - 00:00 | Presenter: Haiyan Zeng
- Abstract
Loading... -
+
P63.13 - Long Term Survival Characteristics in SCLC Patients Receiving Atezolizumab and Chemotherapy
00:00 - 00:00 | Presenter: Anifat Elegbede
- Abstract
Loading... -
+
P63.14 - Three Weekly Irinotecan for Refractory/Relapsed Small Cell Lung Cancer
00:00 - 00:00 | Presenter: snigdha nutalapati
- Abstract
Loading... -
+
P63.15 - Clinical Analysis of 89 Female Patients With Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Fei Teng
- Abstract
Loading...
-
+
P64 - Small Cell Lung Cancer/ NET - Clinical Trial in Progress
- Type: Posters
- Track: Small Cell Lung Cancer/ NET
- Presentations: 4
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P64.01 - The Canadian Small Cell Lung Cancer Database (CASCaDe): A Multi-Institutional Real-World Evidence Collaboration
00:00 - 00:00 | Presenter: Sara Moore
- Abstract
Loading... -
+
P64.02 - EMERGE 402 Phase 4 Observational Study: Safety and Outcomes in Patients With SCLC Receiving Treatment With Lurbinectedin
00:00 - 00:00 | Presenter: Raj Hanvesakul
- Abstract
Loading... -
+
P64.03 - A Phase II Single-Arm Trial of Apatinib as Maintenance Treatment Following First-Line Chemotherapy in Extensive Stage Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Fei Teng
- Abstract
Loading... -
+
P64.04 - Hypo-Fractionated Versus Conventionally Fractionated Radiotherapy for Patients with LS-SCLC: An Open-Label, Randomized, Phase 3 Trial
00:00 - 00:00 | Presenter: Nan Bi
- Abstract
Loading...
-
+
P65 - Small Cell Lung Cancer/ NET - Diagnostic/Imaging
- Type: Posters
- Track: Small Cell Lung Cancer/ NET
- Presentations: 1
- Coordinates: 9/08/2021, 00:00 - 00:00, ePoster Hall
-
+
P65.01 - Are Serum Markers Useful In Patients With Resected Pulmonary High-Grade Neuroendocrine Tumors?
00:00 - 00:00 | Presenter: Kazuo Nakagawa
- Abstract
Loading...
first
prev
